NICO - a national prospective non-interventional Study (NIS) with Nivolumab as Monotherapy or in combination with Ipilimumab in Patients with advanced (inoperable or metastatic) Melanoma to collect real-world data

被引：0
|
作者：
Gutzmer, R. [1 ]
Eigentler, T. [2 ]
Mohr, P. [3 ]
Becker, S. [4 ]
Haferkamp, S. [5 ]
Meiss, F. [6 ]
Pfoehler, C. [4 ]
Satzger, I. [7 ]
Schneider, S. W. [8 ]
Terheyden, P. [9 ]
Ulrich, J. [10 ]
Utikal, J. [11 ]
Weichenthal, M. [12 ]
Weishaupt, C. [13 ]
Zimmer, L. [14 ]
Schadendorf, D. [14 ]
机构：
[1] Hannover Med Sch, Klin Dermatol Allergol & Venerol, Haut Tumor Zentrum, Hannover, Germany
[2] Eberhard Karls Univ Tubingen, Tubingen, Germany
[3] Elbe Kliniken Buxtehude, Buxtehude, Germany
[4] Univ Klinikum Saarlandes, Homburg, Germany
[5] Univ Klinikum Regensburg, Regensburg, Germany
[6] Univ Klinikum Freiburg, Freiburg, Germany
[7] Hannover Med Sch, Hannover, Germany
[8] Univ Klinikum Hamburg Eppendorf UKE, Hamburg, Germany
[9] Univ Klinikum Schleswig Holstein, Lubeck, Germany
[10] Harzklinikum Dorothea Christiane Erxleben GmbH, Quedlinburg, Germany
[11] Univ Klinikum Mannheim, Mannheim, Germany
[12] Univ Klinikum Schleswig Holstein, Kiel, Germany
[13] Univ Klinikum Munster, Munster, Germany
[14] Univ Klinikum Essen, Essen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2018年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P131
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [21] Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study
    Serra-Bellver, Patricio
    Versluis, Judith M.
    Oberoi, Honey K.
    Zhou, Cong
    Slattery, Timothy D.
    Khan, Yasir
    Patrinely, James R.
    da Silva, Ines Pires
    Martinez-Vila, C.
    Cook, Natalie
    Graham, Donna M.
    Carlino, Matteo S.
    Menzies, Alexander M.
    Arance, Ana M.
    Johnson, Douglas B.
    Long, Georgina, V
    Pickering, Lisa
    Larkin, James M. G.
    Blank, Christian U.
    Lorigan, Paul
    EUROPEAN JOURNAL OF CANCER, 2022, 176 : 121 - 132
  • [22] Cabozantinib plus nivolumab in adult patients with advanced or metastatic renal cell carcinoma: A retrospective, non-interventional study in a real-world cohort.
    Hilser, Thomas
    Darr, Christopher
    Niegisch, Guenter
    Schnabel, Marco Julius
    Foller, Susan
    Haeuser, Lorine
    Zschaebitz, Stefanie
    Lewerich, Jonas
    Anders-Meyn, Merle
    Ivanyi, Philipp
    Schlack, Katrin
    Grunwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [23] Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project
    Hilser, Thomas
    Darr, Christopher
    Niegisch, Guenter
    Schnabel, Marco Julius
    Foller, Susan
    Haeuser, Lorine
    Zschaebitz, Stefanie
    Lewerich, Jonas
    Ivanyi, Philipp
    Schlack, Katrin
    Paffenholz, Pia
    Daetwyler, Eveline
    Niedersuess-Beke, Dora
    Gruenwald, Viktor
    CANCERS, 2024, 16 (17)
  • [24] Real world data on the use of nivolumab monotherapy in the treatment of advanced renal cell carcinoma: Interim results from the non-interventional study NORA
    Gruenwald, V.
    Bedke, J.
    von der Heyde, E.
    Herber, M.
    Mueller-Huesmann, H.
    Grimm, M. -O.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 207 - 207
  • [25] Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands
    van Zeijl, Michiel C. T.
    van Breeschoten, Jesper
    de Wreede, Liesbeth C.
    Wouters, Michel W. J. M.
    Hilarius, Doranne L.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    de Groot, Jan Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Boer, Marion Stevense-den A.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Boers-Sonderen, Marye J.
    Suijkerbuijk, Karijn P. M.
    Haanen, John B. A. G.
    van den Eertwegh, Alfons J. M.
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (05) : 197 - 204
  • [26] Real-world outcomes in advanced melanoma patients treated with first-line nivolumab plus ipilimumab
    Kozak, Katarzyna
    Teterycz, Pawel
    Galus, Lukasz
    Mackiewicz, Jacek
    Galwas-Kliber, Katarzyna
    Kaminska-Winciorek, Grazyna
    Brandys, Piotr
    Cybulska-Stopa, Bozena
    Kempa-Kaminska, Natasza
    Zietek, Marcin
    Zubrowska, Justyna
    Dziura, Robert
    Dembinski, Mateusz
    Bereza, Michal
    Czarnecka, Anna Malgorzata
    Rutkowski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma
    Costello, Caitlin
    Davies, Faith E.
    Cook, Gordon
    Vela-Ojeda, Jorge
    Omel, Jim
    Rifkin, Robert M.
    Berdeja, Jesus
    Puig, Noemi
    Usmani, Saad Z.
    Weisel, Katja
    Zonder, Jeffrey A.
    Terpos, Evangelos
    Spencer, Andrew
    Leleu, Xavier
    Boccadoro, Mario
    Thompson, Michael A.
    Romanus, Dorothy
    Stull, Dawn Marie
    Hungria, Vania
    FUTURE ONCOLOGY, 2019, 15 (13) : 1411 - 1428
  • [28] HANNA - real-world evidence from a German, prospective, non-interventional study with nivolumab in patients with squamous cell carcinoma of the head and neck (SCCHN)
    von der Heyde, E.
    Welslau, M.
    Gauler, T.
    Hahn, D.
    Wittekindt, C.
    Mueller-Huesmann, H.
    Bockmuehl, U.
    Mauz, P. -S.
    Waldenberger, D.
    Dietz, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 57 - 57
  • [29] HANNA - REAL-WORLD EVIDENCE FROM A GERMAN, PROSPECTIVE, NON-INTERVENTIONAL STUDY WITH NIVOLUMAB IN PATIENTS WITH RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    von der Heyde, E.
    Welslau, M.
    Gauler, T.
    Hahn, D.
    Wittekindt, C.
    Mueller-Huesmann, H.
    Bockmuehl, U.
    Mauz, P. S.
    Waldenberger, D.
    Dietz, A.
    Singh, P.
    VALUE IN HEALTH, 2019, 22 : S437 - S437
  • [30] Investigation of the Effect of Radiotherapy Prior to Initiation of Treatment with Nivolumab in Patients with Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HSCCN) - Real-World Data from the non-interventional Study (NIS) HANNA
    Gauler, T.
    von der Heyde, E.
    Klautke, G.
    von der Gruen, J.
    Tamaskovics, B.
    Welslau, M.
    Waldenberger, D.
    Dietz, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S107 - S108
12345